IRCT20191013045089N1 IRCT 2020-06-27 Shahid Beheshti University of Medical Sciences Curcumin effect on delayed onset muscle soreness Comparison of the Effectiveness of Curcumin Supplement and Placebo in Improving Symptoms of Delayed Onset Muscle Soreness in Sedentary People 2020-06-09 anticipated 15 Complete https://irct.ir/trial/43179 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Crossover, Purpose: Treatment, Randomization description: The order of placement in the drug and placebo groups and the performing DOMS protocol on the dominant or non-dominant leg will be determined by the block randomization method through blocks of size 4 (using sealed envelope), Blinding description: A triple- blinded trial is designed; knowledge of the treatment assignment is concealed from the people who organize and analyze the data of the study as well as from the subjects. As placebo and drug are exactly the same in shape and color, subjects will not be notified of group allocation status. The statistician will also be unaware of the allocation of individuals to study groups. Only the supervisor will be notified. 4 Delayed Onset Muscle Soreness. Intervention 1: Intervention group: they will take 500 mg Curcumin supplement orally. They continue to take it for up to 7 days. Intervention 2: Control group: they will take placebo orally. They continue to take it up to 7 days. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There are no more information